1Kusne S, Grossi P, Irish W, et al. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients[J]. Transplantation, 1999,68 (8) :1125-1131.
2Wingard JR, Piantadosi S, Burns WH, et al. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy[J]. Rev Infect Dis, 1990,12 ( Suppl 7) : $793-804.
4Ljungman P, de Bock R, Cordonnier C, et al. Practices for cyto- megalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant, 1993,12:399-403.
5Wingard JR, Piantadosi S, Burns WH, et al. Cytomegalovirus in- fections in bone marrow transplant recipients given intensive cy- toreductive therapy. Rev Infect Dis, 1990, 12 Suppl 7: S793- 804.
10Kraus MD, Feran-Doza M, Garcia-Moliner ML. Cytomegalovirus infection in the colon of bone marrow transplantation patients. Mod Pathol, 1998, 11:29-36.
2Ministry of Health of the Peopole's Republic of China. 2012 China AIDS Response Progress Report [ R ]. Beijing: Ministry of Health of the Peo- pole's Republic of China, 2012.
4Malaju MT, Alene GD. Deterrninant factors of pregnant mothers' knowl- edge on mother to child transmission of HIV and its prevention in Gondar town, North West Ethiopia [J]. BMC Pregnancy Childbirth, 2012, 12 : 73.
